StockData
Heartflow, Inc. logo

Heartflow, Inc. (HTFL) stock

HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30547% above fair value
$59.10+3.30 (+5.91%)

Close on Nov 11, 2026Market cap $5.14BP/E –Yield –

Heartflow, Inc. grew revenue 42.8% to $212.08M over the twelve months to Jun 30, 2026. Free cash flow was -$59.18M. At the latest close the market valued the company at $5.14B.

Revenue
$212.08M
+42.8% vs. a year earlier
Operating income
-$80.25M
TTM Q2 2026
Free cash flow
-$59.18M
TTM Q2 2026
EPS, diluted
-$3.17
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$5.14B
P/E ratio
–
Price to sales
24.23
Price to book
18.37
Dividend yield
–
Free cash flow yield
-1.15%

Fundamentals

Revenue
$212.08M
Net income
-$118.37M
EPS, diluted
-$3.17
Free cash flow
-$59.18M
Book value per share
$3.24
Diluted shares
86M

Trading

Next earnings
Nov 11, 2026 (estimated, after the close)
Previous close
$55.80
Open
$56.61
Day's range
$56.61 – $60.66
Volume
2,068,455
Average volume (20 days)
1,622,837
Index membership
Russell 2000 (since Dec 2025), Russell 3000 (since Aug 2025)
52-week range
$20.13 – $60.66
RSI (14 days)
60.3
Volatility (1 year)
78.5%
Relative volume
1.20×

On 1 of our idea list: Institutions accumulating

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodHTFLS&P 500DifferenceHTFL per yearS&P 500 per year
1 month+18.8%-2.4%+21.2 pts
3 months+100.1%-1.2%+101.2 pts
Year to date+102.7%+12.3%+90.5 pts
1 year+73.0%+12.4%+60.5 pts

Four years at a glance

Fiscal years 2022 to 2025 and trailing twelve months, USD

Revenue

$212.08M+42.8% YoY

Gross profit

$169.83M+51.8% YoY

Operating income

-$80.25M

Net income

-$118.37M

EPS, diluted

–

Free cash flow

-$59.18M
Reported periodTrailing twelve months

Press releases

Releases Heartflow filed with the SEC as exhibits to Form 8-K or 6-K

About Heartflow

Surgical & Medical Instruments & Apparatus

Heartflow develops artificial intelligence and computational software to provide non-invasive diagnostic and management solutions for coronary artery disease. The company's core offering, the Heartflow Platform, utilizes deep learning and computational fluid dynamics to construct personalized 3D anatomical models of coronary arteries from coronary computed tomography angiography scans. Key offerings include Heartflow RoadMap Analysis, which visualizes anatomy to streamline radiology workflows; Heartflow FFR CT Analysis, which evaluates fractional flow reserve and blood flow restrictions; and Heartflow Plaque Analysis, which characterizes plaque composition and volume. Its customer base consists of hospitals, outpatient imaging centers, and clinicians such as radiologists and cardiologists.

Company profile, executives and history

Heartflow stock: common questions

What is Heartflow's stock price?

HTFL closed at $59.10 on Nov 11, 2026, up 5.91% on the day. Over the past 52 weeks it traded between $20.13 and $60.66.

What is Heartflow's market cap?

Heartflow was worth $5.14B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is HTFL's P/E ratio?

Heartflow lost money over fiscal 2025 (diluted EPS -$3.17), so it has no meaningful P/E ratio.

How much revenue does Heartflow make?

Heartflow reported revenue of $212.08M for the twelve months to Jun 30, 2026, up 42.8% from a year earlier.

Does Heartflow pay a dividend?

No. Heartflow has not paid a cash dividend over the last twelve months.

When does Heartflow report earnings next?

Heartflow is expected to report Q3 FY2026 results on Nov 11, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has HTFL stock performed over the past year?

Including dividends, HTFL returned +73.0% over the past year, against +12.4% for the S&P 500.

How many HTFL shares are sold short?

6M shares were sold short at the latest FINRA report, 15.86% of the float, or 3.5 days of average trading volume.

Who are Heartflow's competitors?

Companies most similar to Heartflow by business, industry and size include TCMD, KMTS, IRTC, SIBN, CVRX.

See a number that looks wrong?